PATENT CLAIM ANALYSIS

Application Number: 16235889
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "130100"]

Abstract:
Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, depot gel compositions that can be injected into a desired location and which can provide controlled release of a beneficial agent over a short duration of time. The compositions include a low molecular weight biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent.

Claim (Index 38):
The method of  claim 21 , wherein the bupivacaine base or pharmaceutically acceptable salt thereof is released from the composition in a controlled manner over a duration ranging from 24 hours to 2 weeks.

Metadata:
- Claim Count in Document: 125.0
- Percentile: 98.0
- Lexical Diversity: 1.625
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15267070', '10701939', '12924441', '10295814', '10295603']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8125018510945224
- 35 USC 102 Novelty (BERT): 0.5590567195131079
- Combined Prediction Score: 0.787157337936381
- Mean Citation Score: 415.612096
- Max Citation Score: 509.90347
- Similarity Product: 301.7515603733957

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test